Connecting Advanced Biotech with Personalised Clinical Care

Double Filtration Plasmapheresis, commonly known as DFPP, is an advanced extracorporeal blood purification technique. It works by separating plasma from the blood and passing it through specialised filtration membranes designed to reduce selected large-molecular-weight substances from circulation.

At Vega Medical Services, DFPP may be considered for selected patients who require vascular optimization, inflammatory burden reduction, lipid-related support, or immune-related care planning. The procedure is performed under medical supervision and requires careful screening before treatment.

DFPP may be integrated into broader clinical programs, particularly where circulation, blood rheology, inflammation, or metabolic stress may play a role in the patient’s condition. In some cases, it may also be used as a preparatory or supportive step before certain regenerative or cellular programs.

DFPP is designed to support the internal vascular environment by helping reduce selected circulating factors that may affect blood flow, inflammation, and microcirculation. Suitability depends on the patient’s medical condition, blood results, medication history, and physician assessment.

Nicotinamide Adenine Dinucleotide, or NAD+, is an important coenzyme involved in cellular energy production, mitochondrial function, DNA repair pathways, and metabolic regulation. NAD+ levels may decline with aging, chronic stress, metabolic dysfunction, and certain health conditions.

Vega Medical Services provides physician-guided NAD+ intravenous protocols for selected patients seeking cellular energy support, neurological wellness support, metabolic optimization, or age-management care. Intravenous administration allows NAD+ to be delivered directly into circulation under clinical supervision.

Our NAD+ programs are carefully assessed and adjusted based on patient goals, medical history, tolerance, and overall treatment plan. The focus is to support cellular resilience and metabolic function within a responsible medical framework.

NAD+ therapy is intended to support cellular energy pathways and mitochondrial function. It may be used as part of a broader wellness or medical support program, depending on patient suitability and physician recommendation.